Arlington (VA): American Diabetes Association
Typically, patients may begin to notice changes in appetite and weight within a few weeks of starting treatment
Works cited GLP-1 Agonists: What They Are, How They Work & Side Effects - Cleveland Clinic, accessed April 21, 2025, Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor Agonists - PubMed Central, accessed April 21, 2025, Glucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI Bookshelf, accessed April 21, 2025, What To Know About How Weight Loss Medications Work | Jefferson Health, accessed April 21, 2025, Role of GLP-1 Receptor Agonists for Weight Loss - YouTube, accessed April 21, 2025, Don't Worry About Muscle Loss With GLP-1 Inhibitors, Viewpoint Asserts | tctmd.com, accessed April 21, 2025, How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss
Were excited to find ways to continue bringing branded treatments to the platform across specialties
5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 200 mcg dose = 8 units (0.08 mL) on a 100-unit insulin syringe 300 mcg dose = 12 units (0.12 mL) on a 100-unit insulin syringe Doses per vial: 25 doses at 200 mcg, or ~16 doses at 300 mcg Supplies Needed (12-Week Cycle at 200 mcg 3x Daily) 11 vials Ipamorelin (5 mg each) provides 55 mg total, covers 252 doses of 200 mcg with margin 3 vials bacteriostatic water (30 mL each) 252 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Ipamorelin is administered via subcutaneous (SubQ) injection
Phase 3 trials will provide a clearer side-effect picture